Navigation Links
Mersana Reports Preliminary Phase 1 Results of XMT-1001 in Patients with Advanced Solid Tumors
Date:6/1/2009

ients with advanced solid tumors. The objectives of the study are to determine the maximum tolerated dose (MTD) as well as to assess safety and pharmacokinetics. The maximum tolerated dose is not yet defined and accrual to the study continues.

ASCO Poster Information

"A Phase I study of the safety and pharmacokinetics (PK) of XMT-1001 given as an intravenous (IV) infusion once every three weeks to patients with advanced solid tumors."

By E. Sausville, L. Garbo, G. J. Weiss, S. Anthony, D. Shkolny, A. V. Yurkovetskiy, C. Bethune, R. J. Fram; University of Maryland, Baltimore, MD; New York Oncology Hematology, Albany, NY; TGen Clinical Research Services, Scottsdale, AZ; Mersana Therapeutics, Inc., Cambridge, MA; Covance Bioanalytical, Madison, WI

    Session: Developmental Therapeutics: Cytotoxic Chemotherapy
    Type: General Poster Session
    Time: Saturday May 30, 2009, 8:00 AM to 12:00 PM
    Location: Level 2, West Hall C

About Fleximer(R)

The key component of Mersana's platform is Fleximer(R), a novel, biodegradable and bio-inert polymer that can be chemically linked to small molecules and biologics. Fleximer(R) technology improves the therapeutic index of existing compounds by uniquely combining biodegradability with "biological stealth" properties, making Fleximer(R) materials and their conjugates long-circulating and non-immunotoxic. Fleximer(R) molecules are characterized by solubility in water, with stability in common manufacturing procedures.

About Mersana Therapeutics, Inc.

Mersana Therapeutics employs its biodegradable polymer platform (Fleximer(R)) to create new and better medicines. We are advancing our own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications. We also leverage the versatility of Fleximer through partner
'/>"/>

SOURCE Mersana Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Mersana Therapeutics Appoints C. Boyd Clarke Chairman of the Board of Directors
2. Mersana Therapeutics, Inc. Appoints Chief Scientific Officer, Timothy B. Lowinger, Ph.D.
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. QMed, Inc. Reports July Medicare SNP Enrollments
5. Phlo Affiliate Reports Expanded Coverage to Oregon Border
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
8. Carrington Reports Second Quarter 2007 Results
9. Avitar Reports Third Quarter Financial Results for Fiscal 2007
10. Response Genetics Reports Second Quarter 2007 Financial Results
11. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...Md., Nov. 20 Novavax, In...iced an underwritten public offering of 6,800,000 ...c of $3.30 per share. The approximately $21 milli...ng discounts and commissions, will be used for pre...sed vaccines, internal research and development pr...
(Date:11/20/2009)... METTLER TOLEDO recently announced that Dr. Domin...The Role of Process Analytical Technology (PAT) in...ecember 1, 2009. , (PRWEB...cess Analytical Technology (PAT) in Green Chemistr...ocess Analytical Technology (PAT) case studies wil...
(Date:11/19/2009)...., Nov. 19 Dr. Mate Hidvegi, inven...ds to a press release issued on November 17 by Bir...r making false and self-serving statements about i.... Hidvegi stated from his office in Budapest, Hung... Avemar does not apply to AveULTRA, www.aveultra...
(Date:11/19/2009)...Pa. and WALTHAM, Mass., Nov. 19 Ar...rces find that the leading driver of antibiotic se...-spectrum activity against gram-positive and gram-...s that can cause nosocomial pneumonia, surveyed Eu...for agents that provide appropriate coverage again...
Breaking Biology Technology:Novavax Prices Public Offering of Common Stock 2Process Analytical Technology (PAT) in Green Chemistry and Green Engineering 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...n, one of the first rituals after shaking hands is...r card. In the business world, it is a reflex reac...tic. , ,When I visited Japan a few years ago, I h...usiness card was so important to the Japanese that...hee). I learned to take a card carefully with both...
...Can the UW-Madison survive as a public university ...ts budget? , ,Thats the question being posed these...elieves the universitys role as a catalyst for Wis...sh if state investment in higher education stalls.... less accessible to students from middle-class and...
...nologies, nationwide power-monitoring system is c...utage Task Force in its newly released report in...t that affected large portions of the Midwest and ...The Federal Energy Regulatory Commission (FERC) an...,s I-Grid for analysis, as well as from other util...
Other Biology Technology:Are You Your Business Card? 2Are You Your Business Card? 3UW-Madison Chancellor Wiley Challenges State to Think About Universitys Future 2UW-Madison Chancellor Wiley Challenges State to Think About Universitys Future 3
(Date:11/23/2009)...re a nasty business, posing dangers to human healt...sity is launching a new project with funding from ...t targets the fat and grease that contribute to mi...n planners new tools to further reduce the risk of...anitary" sewer systems, as opposed to "combined" s...
(Date:11/23/2009)...available in German . , Of all global carbo...the atmosphere where it contributes to global warm...rrestrial ecosystems such as forests, grasslands a...aquatic and terrestrial ecosystems is considered o...cing climate change. However, new greenhouse gas b...
(Date:11/22/2009)...ing South Korean scientists have succeeded in prod...ugh bioengineering, rather than through the use of...research, which may now allow for the production o... in two papers in the journal Biotechnology and B...ary. , Polymers are molecules found in everyday...
Breaking Biology News(10 mins):Lose the fat: Targeting grease to curtail sewer overflows 2Intensive land management leaves Europe without carbon sinks 2Bioengineers succeed in producing plastic without the use of fossil fuels 2Pluromed Inc Signs Agreement with Boston Scientific 59122 1Pluromed Inc Signs Agreement with Boston Scientific 59122 2Pluromed Inc Signs Agreement with Boston Scientific 59122 3Jackson 26amp 3B Coker Investigates the Impact of Social Media on Hospitals and Physicians 59119 1Jackson 26amp 3B Coker Investigates the Impact of Social Media on Hospitals and Physicians 59119 2Jackson 26amp 3B Coker Investigates the Impact of Social Media on Hospitals and Physicians 59119 3Jackson 26amp 3B Coker Investigates the Impact of Social Media on Hospitals and Physicians 59119 4Jackson 26amp 3B Coker Investigates the Impact of Social Media on Hospitals and Physicians 59119 5ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego CA 59117 1ONRAD Announces New Partnership with La Maestra Community Health Centers of San Diego CA 59117 2
...is S. Collins, M.D., Ph.D., a physician-geneticist...named recipient of the inaugural Inamori Ethics Pr...cs and Excellence at Case Western Reserve Universi... international ethical leaders. It is presented an...lary ethical leadership and whose actions and infl...
...one who has seen Kansas prairies in late summer to...ers decorating fields and lining roadways, giving ...tate. , Despite its beauty, the sunflower is more... Mark Ungerer, assistant professor in the Division...ime example of the unique adaptability of plants. ...
...stacle when it comes to starting a business. Thats...chemist Empire, Inc., who invented a trading card ...tudents in a fun, unusual way. , At the 235th Nat...New Orleans, Samar will present his inventive card..., this precocious CEO hopes to secure $500,000 in ...
Other Biology News:Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve 2Geneticist Francis Collins named first recipient of Inamori Ethics Prize at Case Western Reserve 3Kansas state flower receives scientific attention 214-year-old CEO makes chemistry a game with 'Elementeo' 2
...XPRESS 2D Proteomic Imaging System, Professional P...n Over a Wide Dynamic Range: The ProXPRESS 2D Prot...ing system for both proteomic and general life sci...unparalleled flexibility, enabling the use of all ...
... T2-01 high-performance pump, available in a singl... efficiency dynamic valve design. With the most co...e, T2-01 is ideal for use in portable air and gas ... (T2-01 SH and T2-01TH). , Delivers 1.5 and 2.0 li...
...cription: ,Kit containing Dermal Fibroblasts (rab...taining 20% FBS and 10% DMSO at passage 25 (approx...This cell culture is supplied as a long-term cultu...onths of continuous growth from the date supplied,...
... containing Vaginal Keratinocyte Progenitors, Rabb...aining 20% FBS and 10% DMSO at passage 25 (approx)...his cell culture is supplied as a long-term cultur...nths of continuous growth from the date supplied, ...
Biology Products: